MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 12, Pages 64: Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring (Pharmaceuticals)

 
 

24 april 2019 07:02:43

 
Pharmaceuticals, Vol. 12, Pages 64: Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring (Pharmaceuticals)
 


In this study, 48 inhibitors were docked to 107 allosteric centers of human immunodeficiency virus 1 (HIV-1) reverse transcriptase from the Protein Data Bank (PDB). Based on the average binding scores, quantitative structure-activity relationship (QSAR) equations were constructed in order to elucidate directions of further development in the design of inhibitors. Such developments, informed by structural data, must have a focus on activity against mutated forms of the enzyme, which are the cause of the emergence of multidrug-resistant viral strains. Docking studies employed the HYDE scoring function. Two types of QSARs have been considered: One based on topological descriptors and the other on structural fragments of the inhibitors. Both methods gave similar results, indicating substructures favoring binding to mutated forms of the enzyme.


 
116 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 12, Pages 63: Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines (Pharmaceuticals)
Pharmaceuticals, Vol. 12, Pages 65: Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten